Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury
多模式干预改善脊髓损伤的功能和代谢
基本信息
- 批准号:10159744
- 负责人:
- 金额:$ 103.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-21 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AchievementAddressAerobicAgeAmericanAndrogensAnemiaAnxietyAreaAttentionAutonomic DysfunctionBody fatCaringChronicClinical Trials DesignDecanoatesErgometryEventExerciseExercise TherapyFPS-FES OncogeneFatty acid glycerol estersFemaleHealthHigh PrevalenceHomeHormonesHybridsImpairmentIndividualInflammationInjectionsInjuryInsulin ResistanceInterventionLegLifeLinkLipidsLower ExtremityMedical centerMetabolicMetabolismModalityMonitorMoodsMorbidity - disease rateMuscleMuscle functionMuscular AtrophyMusculoskeletalNandroloneOutcomePainParalysedParticipantPatient Outcomes AssessmentsPatient Self-ReportPatientsPerformancePersonal SatisfactionPersonsPharmacologic SubstancePhysical CapacityPhysical ExercisePhysical FunctionPhysiologicalPlacebosPlasmaPublic HealthQuality ControlQuality of lifeRandomizedRecovery of FunctionReportingResearchSpinal cord injurySpinal cord injury patientsSupervisionTelephoneTestingTrainingVisceral fatVisiting NurseWorkloadarmbasebody systemcardiometabolismcomputerizedefficacy outcomesefficacy trialexercise intensityexercise interventionfasting glucosefunctional electrical stimulationimprovedimproved functioningindexinginflammatory markerinsulin sensitivitylaboratory experimentlean body massmalemenmortalitymotor function improvementmulti-component interventionmultimodalitymuscle formmuscle strengthneuromuscular stimulationpain sensitivitypatient safetyprimary outcomeprogramsrandomized trialrehabilitation researchresponsesatisfactionsecondary outcomeselective androgen receptor modulatorsextreatment armtrial design
项目摘要
Over 250,000 Americans are living with paralysis resulting from spinal cord injury (SCI), one of the most
grievous events in a person's life. Inter-linked deficits in multiple physiologic organ systems in persons with SCI
contribute to a vicious cycle of progressively declining musculoskeletal and cardiometabolic health, and
wellbeing. In recognition of the profoundly deleterious effects of chronic SCI on an individual's health, the
National Center for Medical Rehabilitation Research (NCMRR) has deemed “pharmaceutical, stimulation, and
exercise…strategies to improve the motor function and health of SCI patients” a priority area of research. The
NCMRR has further emphasized efficacy trials of multicomponent interventions, as this application proposes to
accomplish. There is evidence - mostly from nonrandomized studies - that arm ergometry and functional
electrical stimulation of the lower extremity during leg cycling (FES-LC) improve physical capacity of SCI
patients. However, the aerobic demands and workloads achieved by arm ergometry or FES-LC alone are often
not of sufficient intensity to induce optimal musculoskeletal and metabolic adaptations. SCI is associated with
high prevalence of androgen deficiency, which further contributes to muscle loss, metabolic dysregulation, and
low mood. By combining FES-LC with concurrent arm ergometry (“hybrid” training), substantially higher levels
of exercise intensity can be achieved than with either intervention alone. The effects of hybrid exercise on
muscle mass, strength, and function are augmented by androgen administration. Furthermore, androgen may
have additional beneficial effects in improving mood, wellbeing, pain sensitivity, and metabolic outcomes.
We hypothesize that a Home-Based Multimodality Functional Recovery and Metabolic Health Enhancement
Program that includes concurrent FES-LC and arm ergometry, and an androgen (19-nortestosterone
decanoate, 19ND) would be more efficacious than arm ergometry alone in improving aerobic capacity, muscle
mass and strength, metabolic health, self-reported function and mobility, and wellbeing. This hypothesis will be
tested in a randomized trial in 84 persons with C7 to T12 SCI, AIS grade A, B or C, 6 months or later after SCI.
Participants will be randomized to either the multi-modality intervention or arm ergometry alone for 16 weeks.
After 2-weeks of training in the exercise laboratory, the intervention will be conducted in the participant's home,
using video monitoring of the home exercise. Primary outcome is peak aerobic capacity. Secondary outcomes
include self-reported function and mobility assessed using computerized adaptive test version of Spinal Cord
Injury-Functional Index; muscle mass, strength and fatigability; fat mass and distribution; metabolism (insulin
sensitivity; lipids; inflammatory markers); wellbeing (mood, anxiety, pain, and life satisfaction). An inter-
disciplinary team, access to a large patient pool, rigorous trial design, assiduous attention to patient safety and
statistical power, and inclusion of performance-based and patient-reported outcomes should facilitate the
accomplishment of the proposed aims, which have implications for improving the care of SCI patients.
超过25万名美国人因脊髓损伤(SCI)导致瘫痪而生活,这是最多的美国人之一
一个人一生中的悲剧事件。链接在多个生理器官系统中定义了SCI的人
有助于逐渐下降的肌肉骨骼和心脏代谢健康的恶性循环,以及
福利。认识到慢性SCI对个人健康的严重删除的影响
国家医学康复研究中心(NCMRR)认为“药物,刺激和
锻炼…改善SCI患者运动功能和健康的策略”研究的优先领域。
NCMRR进一步强调了多组分干预措施的效率试验,因为该应用程序提议
完成。有证据 - 大多来自非随机研究 - 手臂的测能和功能
腿部骑行期间下肢的电刺激(FES-LC)提高了SCI的身体能力
患者。但是,仅手臂或FES-LC实现的有氧需求和工作量通常是
没有足够的强度来诱导最佳的肌肉骨骼和代谢适应。 SCI与
雄激素缺乏症的高患病率进一步导致肌肉丧失,代谢失调和
情绪低落。通过将FES-LC与并发的ARM测能法(“混合”训练)相结合,高度更高
与仅在任何一种干预措施中都可以实现运动强度。混合练习对
雄激素给药增强了肌肉质量,力量和功能。此外,雄激素可能
在改善情绪,福祉,疼痛敏感性和代谢结果方面具有额外的有益作用。
我们假设一个基于家庭的多模式功能恢复和代谢健康增强
程序包括并发的FES-LC和ARM测能法,以及雄激素(19-北植物)
decanoate,第19届)比单独的手臂在提高有氧运动能力,肌肉方面更有效
质量和力量,代谢健康,自我报告的功能和流动性以及福祉。这个假设将是
在SCI后6个月或更晚的6个月后,在84名C7至T12 SCI,AIS A,B或C的随机试验中进行了测试。
参与者将单独将其随机分配给多模式干预措施或单独的手臂测量法。
在运动实验室进行了2周的培训后,将在参与者的家中进行干预,
使用家庭锻炼的视频监控。主要结果是峰值有氧能力。次要结果
包括自我报告的功能和使用计算机化自适应测试版本的脊髓评估的机动性
伤害功能指数;肌肉质量,力量和疲劳性;脂肪质量和分布;代谢(胰岛素
灵敏度;脂质;炎症标记);健康(情绪,焦虑,痛苦和生活满意度)。一个间
纪律团队,进入大型患者池,严格的试用设计,有助于注意患者安全和
统计能力以及包括基于绩效和患者报告的结果的统计能力应促进
拟议目的的实现,对改善SCI患者的护理具有影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHALENDER BHASIN其他文献
SHALENDER BHASIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHALENDER BHASIN', 18)}}的其他基金
NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial
NAD 增强治疗糖尿病肾病:一项随机对照试验
- 批准号:
10430705 - 财政年份:2022
- 资助金额:
$ 103.03万 - 项目类别:
NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial
NAD 增强治疗糖尿病肾病:一项随机对照试验
- 批准号:
10668324 - 财政年份:2022
- 资助金额:
$ 103.03万 - 项目类别:
A Proof of Concept Trial of a Sirtuin-NAD+ Activator in Alzheimer's Disease
Sirtuin-NAD 激活剂治疗阿尔茨海默病的概念验证试验
- 批准号:
10311161 - 财政年份:2021
- 资助金额:
$ 103.03万 - 项目类别:
A Proof of Concept Trial of a Sirtuin-NAD+ Activator in Alzheimer's Disease
Sirtuin-NAD 激活剂治疗阿尔茨海默病的概念验证试验
- 批准号:
10457489 - 财政年份:2021
- 资助金额:
$ 103.03万 - 项目类别:
A Proof of Concept Trial of a Sirtuin-NAD+ Activator in Alzheimer's Disease
Sirtuin-NAD 激活剂治疗阿尔茨海默病的概念验证试验
- 批准号:
10634622 - 财政年份:2021
- 资助金额:
$ 103.03万 - 项目类别:
Improving Quality of Life of Prostate Cancer Survivors with Androgen Deficiency
改善雄激素缺乏的前列腺癌幸存者的生活质量
- 批准号:
10398005 - 财政年份:2018
- 资助金额:
$ 103.03万 - 项目类别:
Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury
多模式干预改善脊髓损伤的功能和代谢
- 批准号:
9767249 - 财政年份:2018
- 资助金额:
$ 103.03万 - 项目类别:
Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury
多模式干预改善脊髓损伤的功能和代谢
- 批准号:
10398790 - 财政年份:2018
- 资助金额:
$ 103.03万 - 项目类别:
Improving Quality of Life of Prostate Cancer Survivors with Androgen Deficiency
改善雄激素缺乏的前列腺癌幸存者的生活质量
- 批准号:
9918241 - 财政年份:2018
- 资助金额:
$ 103.03万 - 项目类别:
Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury
多模式干预改善脊髓损伤的功能和代谢
- 批准号:
10764596 - 财政年份:2018
- 资助金额:
$ 103.03万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Dynamic Nuclear Polarization MR Spectroscopic Imaging for Diagnosis and Treatment Response Assessment in Hepatocellular Carcinoma
动态核偏振磁共振波谱成像用于肝细胞癌的诊断和治疗反应评估
- 批准号:
10367551 - 财政年份:2022
- 资助金额:
$ 103.03万 - 项目类别:
Dynamic Nuclear Polarization MR Spectroscopic Imaging for Diagnosis and Treatment Response Assessment in Hepatocellular Carcinoma
动态核偏振磁共振波谱成像用于肝细胞癌的诊断和治疗反应评估
- 批准号:
10546479 - 财政年份:2022
- 资助金额:
$ 103.03万 - 项目类别:
Multicomponent Behavioral Sleep Intervention for Insomnia in Older Adults with Mild Cognitive Impairment
多成分行为睡眠干预治疗轻度认知障碍老年人失眠
- 批准号:
10210301 - 财政年份:2019
- 资助金额:
$ 103.03万 - 项目类别:
Multicomponent Behavioral Sleep Intervention for Insomnia in Older Adults with Mild Cognitive Impairment
多成分行为睡眠干预治疗轻度认知障碍老年人失眠
- 批准号:
9923768 - 财政年份:2019
- 资助金额:
$ 103.03万 - 项目类别:
Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury
多模式干预改善脊髓损伤的功能和代谢
- 批准号:
9767249 - 财政年份:2018
- 资助金额:
$ 103.03万 - 项目类别: